Breast cancer regulation by traffic and degradation of ErbB family
Breast cancer regulation by traffic and degradation of ErbB family
批准号:
22791265
负责人:
SAKURAI Yu
金额:
$2.58万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Young Scientists (B)
财政年份:
2010
资助国家:
日本
项目状态:
已结题
起止时间:
2010 至 2011
中文摘要
ERBB2/ErbB3异源二聚体在多种乳腺癌中均有表达,该二聚体产生的信号在乳腺癌的恶性表型中起重要作用。在目前的研究中,我分析了杂二聚体是如何被降解的。ErbB2相对稳定,ErbB3被蛋白酶体和溶酶体持续降解。NRG1β刺激可诱导蛋白酶体依赖性降解。在测试的几个E3中,我鉴定了Nrdp1和另外两个泛素化ErbB3的E3。此外,ErbB3的胞内部分需要100个氨基酸的复合才能降解,这表明ErbB3可能是泛素化的靶点。
英文摘要
ErbB2/ErbB3 heterodimer is expressed on many breast cancers, and the signals derived from the dimer plays significant roles on malignant phenotypes. In the present study, I analyzed how the heterodimer is degraded. Whereas ErbB2 was relatively stable, ErbB3 was continuously degraded by the proteasome and lysosomes. NRG1βstimulation induced proteasome-dependent degradation. Among several E3s tested, I identified Nrdp1 and two additional E3s that ubiquitinated ErbB3.Further, intracellular portion of ErbB3 comprizing of 100 aminoacids was required for the degradation, suggesting the possible ubiquitination target of ErbB3.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
若年者乳癌症例の治療・妊孕性についての検討
年轻乳腺癌病例的治疗和生育能力检查
DOI:
--
发表时间:
2011
期刊:
影响因子:
--
作者:
[上原範久, 兼松清果, 三城弥範, 義澤克彦, 螺良愛郎, 櫻井遊]
通讯作者:
櫻井遊
乳癌術後療法の方針決定と予後因子についての検討
乳腺癌术后治疗决策及预后因素的考虑
DOI:
--
发表时间:
2010
期刊:
影响因子:
--
作者:
[上原範久, 兼松清果, 三城弥範, 義澤克彦, 螺良愛郎, 櫻井遊, 櫻井遊]
通讯作者:
櫻井遊
Development of siRNA delivery system tot tumor vesssels: optimization of intracellular trafficking and pharmacokinetics
-
批准号:25893001
-
项目类别:Grant-in-Aid for Research Activity Start-up
-
资助金额:$1.75万
-
财政年份:2013
-
负责人:SAKURAI Yu
-
依托单位:
海外基金